研究者総覧 - 炭本　隆宏

スミモト　タカヒロ
炭本　隆宏

所属大分大学医学部附属病院中診特診・薬剤部

職種助教

論文
論文	Impact of cancer cachexia progression on OATP1B activity: Quantitative analysis using coproporphyrin-I. 23rd International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT) 2025 2025/09
論文	Development and validation of simultaneous quantification of total and free clozapine and its two metabolites in human plasma using ultra high-performance liquid chromatography coupled to tandem mass spectrometry Journal of Chromatography B,124763-124763頁 2025/08
論文	Wide-range and high-throughput quantification of anamorelin in human plasma using ultra-high-performance liquid chromatography coupled to tandem mass spectrometry. Clinical biochemistry 138,110949-110949頁 2025/05/13
論文	Clinical relevance of immune checkpoint inhibitors for the analgesic effect of opioids: A retrospective propensity score analysis British Journal of Clinical Pharmacology 2025/04/28
論文	Impact of Cancer Cachexia Progression on OATP1B1 Transport Activity: Quantitative Analysis Using Coproporphyrin‐I as an Endogenous Biomarker Clinical Pharmacology & Therapeutics 2025/03/17
論文	Comparison of Efficacy, Safety, and Economic Outcomes Between Biosimilar ABP 215 and Originator Bevacizumab in Japanese Patients With Colorectal Cancer Cureus 2024/10/24
論文	ペメトレキセドの先発品と後発品の調製効率ならびに治療学的安全性の比較癌と化学療法 51 (6),637-641頁 2024/06
論文	Cathepsin G-induced malignant progression of MCF-7 cells involves suppression of PAF signaling through induced expression of PAFAH1B2 Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1867 (8),159164-159164頁 2022/08
論文	Development of a Sensitive and High-Throughput Assay for Simultaneous Quantification of 5 Tyrosine Kinase Inhibitors and 2 Active Metabolites in Human Plasma Using Ultra-high Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry Therapeutic Drug Monitoring 44 (3),419-429頁 2022/06
論文	Exacerbation of cancer pain after administering immune checkpoint inhibitor in a patient taking opioids: A case report Journal of Clinical Pharmacy and Therapeutics 47 (4),552-555頁 2022/04
論文	Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction Clinical Case Reports 9 (8) 2021/08/16
論文	トラスツズマブの先行バイオ医薬品とバイオ後続品の治療学的安全性の比較癌と化学療法 48 (7),945-949頁 2021/07
論文	院内製剤業務支援システムの開発と有用性の評価医療情報学 40 (5),247-255頁 2021/01/27
論文	不眠症治療薬の種類および服用量と転倒率との関連性診療と新薬 56 (8),576-581頁 2019/08
論文	Successful determination of nilotinib dosage by therapeutic drug monitoring in a patient with chronic myeloid leukemia developing hepatic dysfunction: A case report Clinical Case Reports 7 (7),1419-1421頁 2019/06/14
論文	糖尿病患者における配合剤に関する意識調査診療と新薬 55 (11),862-867頁 2018/11
論文	Sensitive and high-throughput UPLC-MS/MS method for simultaneous quantification of imatinib, N-desmethyl-imatinib, nilotinib, dasatinib, bosutinib, ponatinib and N-desmethyl-ponatinib in human plasma. 16th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology 2018/09
論文	Filgrastim biosimilar for neutropenia in gynecological cancer patients receiving chemotherapy: A prospective, single-center, non-randomized, open trial Pharmazie 73 (8),486-488頁 2018/06
論文	A quantitative method for the determination of bosutinib in human plasma using high‐performance liquid chromatography and ultraviolet detection Journal of Clinical Laboratory Analysis 2018/01
論文	Determination of nilotinib with high-performance liquid chromatography in human plasma from patients with chronic myelogenous leukemia, and its applications. 45th ESCP Annual Symposium Clinical pharmacy tackling inequalities and access to health care. 2016/10